Decision Counseling and Follow-up for Shield+ Patients

Starting soon

Conditions studied: Colo-rectal Cancer

In brief

Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.

Key facts

Study ID

NCT07620535

Run by

Guardant Health, Inc.

People needed

350

Starts

2026-06-01

Expected to finish

2028-06-01

Last updated by the study team

2026-06-02

Who can join

Age: 45 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participant is 45-75 years old at the time of ShieldTM test order.
• Participant has a valid Shield(+) test result.
• Participant is willing and able to complete the informed consent process
• Participant is able to complete the informed consent process and decision counseling session in English

You may not qualify if…

• Participant is already enrolled in another Guardant Health, Inc. clinical study or has received a positive MCD result for a cancer type other than CRC.

Where it is running

• Jefferson Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.